Autolus outlines $140M-$150M 2026 AUCATZYL revenue, targets 65%-70% gross margin in 12-18 months — See source for full details.
$AUTL
Price history, market instrument context, member research, and related headlines in one place.
AUTL key statistics
NasdaqGSUSD
52-week range
$1.1837%$2.58
Latest session $1.60–$1.70Autolus Therapeutics plc (AUTL) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $1.69, up $0.07 (4.32%) from the previous close of $1.62. It has traded between $1.60 and $1.70 in the latest session. Over the past year it has ranged from $1.18 to $2.58, leaving it in the lower half of its 52-week range (37%). Reported volume for the session was 2.6M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Autolus Therapeutics Q2 2026 Earnings Preview — See source for full details.
Loading $AUTL research…